The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 15, 2024
Filed:
Sep. 07, 2022
Applicant:
Rigel Pharmaceuticals, Inc., Indianapolis, IN (US);
Inventors:
Esteban Masuda, Menlo Park, CA (US);
Simon Shaw, Oakland, CA (US);
Vanessa Taylor, San Francisco, CA (US);
Somasekhar Bhamidipati, Foster City, CA (US);
Assignee:
RIGEL PHARMACEUTICALS, INC., South Sanfrancisco, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 413/12 (2006.01); A61K 31/553 (2006.01); A61P 35/00 (2006.01); C07D 267/14 (2006.01); C07D 413/14 (2006.01); C07D 487/04 (2006.01);
U.S. Cl.
CPC ...
C07D 267/14 (2013.01); A61P 35/00 (2018.01); C07D 413/12 (2013.01); C07D 413/14 (2013.01); C07D 487/04 (2013.01);
Abstract
Disclosed herein are kinase inhibitory compounds, such as a receptor-interacting protein-1 (RIP1) kinase inhibitor compounds, as well as pharmaceutical compositions and combinations comprising such inhibitory compounds. The disclosed compounds, pharmaceutical compositions, and/or combinations may be used to treat or prevent a kinase-associated disease or condition, particularly a RIP1-associated disease or condition.